GleamWall
中文EN

JUSH Jushi Holdings Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1909747 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.2%
TTM net income YoY15.7%
TTM EPS YoY15.2%
Revenue 3-yr CAGR-0.2%
Net income 3-yr CAGR—

Margins

Gross margin44.2%
Operating margin2.4%
Net margin-20.0%
FCF margin2.2%
EBITDA margin11.1%

Returns

ROE—
ROA-12.9%
ROIC (approx.)8.6%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets136.3%
Debt / equity—
Current ratio0.79x
Interest coverage0.16x

Cash quality & payout

Operating cash flow / net income-0.34x
Accruals ratio-17.3%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q3*2026-09-302026Q2*2026-06-302026Q1*2026-03-312025Q4*2025-12-312025Q3*2025-09-302025Q2*2025-06-302025Q1*2025-03-312024Q4*2024-12-31
Income statement
Revenue$70.47M$71.30M$66.43M$68.34M$65.68M$65.05M$63.85M$65.86M
Cost of revenue$38.14M$39.77M$36.55M$39.72M$35.02M$36.12M$38.07M$40.45M
Gross profit$32.33M$31.53M$29.88M$28.61M$30.66M$28.92M$25.77M$25.41M
SG&A expense$28.75M$29.31M—$24.84M$28.02M$28.75M——
Operating income$3.51M$714,000$1.58M$782,000$2.34M$3.60M-$1.87M-$1.84M
Interest expense$10.40M$10.10M$10.48M$10.47M$10.38M$10.33M$10.12M$9.51M
Income tax$6.78M-$976,000$8.72M$7.25M$8.83M$9.93M$8.98M$3.59M
Net income-$12.52M-$7.33M-$19.85M-$15.56M-$23.69M-$12.33M-$17.02M-$12.47M
EBITDA$7.35M$5.81M$9.53M$7.97M$6.55M$8.04M$6.16M$6.07M
EPS (basic)-0.06-0.04-0.10—-0.12-0.06-0.09—
EPS (diluted)-0.06-0.04-0.10—-0.12-0.06-0.09—
Weighted avg. shares (diluted)198.20M198.20M198.16M—195.20M195.20M195.20M—
Balance sheet
Cash & equivalents$28.73M$33.33M$39.70M$24.05M$26.16M$25.23M$27.89M$21.35M
Receivables$4.46M$4.19M$3.73M$2.80M$872,000$791,000$1.40M$1.46M
Inventory$35.14M$34.30M$35.60M$34.61M$36.80M$34.23M$34.34M$36.14M
Current assets$74.13M$77.17M$84.68M$68.31M$68.60M$64.23M$68.65M$72.15M
PP&E, net$136.15M$137.18M$141.28M$143.32M$144.46M$144.73M$143.39M$144.06M
Goodwill$30.91M$30.91M$30.91M$30.91M$30.91M$30.91M$30.91M$30.91M
Intangibles$88.23M$90.54M$92.78M$92.20M$94.80M$97.02M$98.91M$100.47M
Total assets$424.94M$429.80M$435.13M$422.34M$431.70M$432.37M$433.62M$440.32M
Current liabilities$93.59M$93.17M$75.08M$66.19M$109.19M$63.12M$60.58M$68.89M
Short-term debt$32.37M$33.62M$12.89M$6.64M$48.89M$7.09M$3.85M$2.76M
Long-term debt$194.47M$196.38M$218.47M$199.19M$155.69M$192.83M$193.05M$183.45M
Total debt$226.84M$230.00M$231.35M$205.83M$204.58M$199.91M$196.90M$186.21M
Total liabilities$578.98M$571.61M$569.93M$537.69M$533.17M$510.21M$499.50M$490.56M
Shareholders' equity-$154.04M-$141.82M-$134.80M-$115.34M-$101.47M-$78.14M-$66.18M-$50.23M
Net debt$198.10M$196.67M$191.65M$181.79M$178.42M$174.68M$169.01M$164.86M
Shares outstanding199.71M———————
Cash flow statement
Operating cash flow$3.54M$793,000$8.61M$6.05M$6.08M-$1.94M$7.53M$7.15M
Capital expenditure$2.90M$3.89M$3.03M$3.09M$4.87M$4.12M$4.02M$2.17M
Free cash flow$637,000-$3.10M$5.58M$2.96M$1.21M-$6.05M$3.51M$4.98M
Investing cash flow-$2.93M-$3.90M-$4.08M-$3.07M-$5.32M-$459,000-$4.38M-$7.26M
Financing cash flow-$5.20M-$3.71M$11.12M-$2.52M$166,000-$262,000$3.39M-$1.44M
Depreciation & amortization$3.84M$5.10M$7.95M$7.19M$4.21M$4.43M$8.04M$7.91M
Stock-based compensation$287,000$312,000$392,000$1.68M$357,000$374,000-$307,000$1.27M

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.